{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:49:40Z","timestamp":1790887780400,"version":"4.1.0"},"reference-count":9,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.573527","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T13:51:45Z","timestamp":1602078705000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Development of Extragenital Lichen Sclerosus in Malignant Melanoma Patients Treated With Ipilimumab in Combination With Nivolumab"],"prefix":"10.3389","volume":"10","author":[{"given":"S. Morteza","family":"Seyed Jafari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Feldmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Hunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-018-0676-z","article-title":"Melanoma and immune checkpoint inhibitors.","volume":"20","author":"Furue","year":"2018","journal-title":"Curr Oncol Rep."},{"key":"B2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/ced.14092","article-title":"Nivolumab-associated extragenital lichen sclerosus et atrophicus.","volume":"45","author":"di Meo","year":"2020","journal-title":"Clin Exp Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1111\/ced.13825","article-title":"Nivolumab PD-1 inhibitor immunotherapy associated with vulvar, perineal and perianal lichen sclerosus.","volume":"44","author":"Wernham","year":"2019","journal-title":"Clin Exp Dermatol."},{"key":"B4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma.","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/1346-8138.12779","article-title":"Colocalization of nonsegmental vitiligo and extragenital lichen sclerosus in a 45-year-old female patient with Hashimoto\u2019s thyroiditis.","volume":"42","author":"Kim","year":"2015","journal-title":"J Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40257-012-0006-4","article-title":"Diagnosis and treatment of lichen sclerosus: an update.","volume":"14","author":"Fistarol","year":"2013","journal-title":"Am J Clin Dermatol."},{"key":"B7","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/jid.2011.369","article-title":"An autoimmune phenotype in vulvar lichen sclerosus and lichen planus: a Th1 response and high levels of microRNA-155.","author":"Terlou","year":"2012","journal-title":"J Invest Dermatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1468-3083.2011.04037.x","article-title":"Differential expression of connective tissue growth factor and extracellular matrix proteins in lichen sclerosus.","volume":"26","author":"Gambichler","year":"2012","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/hs9.0000000000000244","article-title":"Mechanisms of action for different checkpoint inhibitors.","volume":"3","author":"Berraondo","year":"2019","journal-title":"HemaSphere"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.573527\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T17:58:50Z","timestamp":1617731930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.573527\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":9,"alternative-id":["10.3389\/fonc.2020.573527"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.573527","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"article-number":"573527"}}